Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 166

1.

Modeling Challenges of Ebola Virus-Host Dynamics during Infection and Treatment.

Chertow DS, Shekhtman L, Lurie Y, Davey RT, Heller T, Dahari H.

Viruses. 2020 Jan 16;12(1). pii: E106. doi: 10.3390/v12010106.

2.

Progressive small bowel obstruction in a patient with the autoimmune syndrome APECED.

Ferré EMN, Heller T, Lionakis MS.

Gastroenterology. 2020 Jan 13. pii: S0016-5085(20)30087-1. doi: 10.1053/j.gastro.2019.12.040. [Epub ahead of print] No abstract available.

PMID:
31945373
3.

Elevated Serum α-Fetoprotein is Associated with Abbreviated Survival for Patients with Fibrolamellar Hepatocellular Carcinoma Who Undergo a Curative Resection.

McDonald JD, Gupta S, Shindorf ML, Gamble LA, Ruff SM, Drake J, Heller T, Wan JY, Dickson PV, Glazer ES, Davis JL, Deneve JL, Hernandez JM.

Ann Surg Oncol. 2020 Jan 10. doi: 10.1245/s10434-019-08178-x. [Epub ahead of print]

PMID:
31925595
4.

Spontaneous clearance of chronic delta hepatitis.

Kapuria D, Ben Yakov G, Koh C, Heller T.

Hepatology. 2019 Dec 23. doi: 10.1002/hep.31073. [Epub ahead of print]

PMID:
31872446
5.

The Delta-4 fibrosis score (D4FS): A novel fibrosis score in chronic hepatitis D.

Da BL, Surana P, Kleiner DE, Heller T, Koh C.

Antiviral Res. 2019 Dec 16;174:104691. doi: 10.1016/j.antiviral.2019.104691. [Epub ahead of print]

PMID:
31837393
6.

Hepatitis C Guidance 2019 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.

Ghany MG, Marks KM, Morgan TR, Wyles DL, Aronsohn AI, Bhattacharya D, Broder T, Falade-Nwulia OO, Feld JJ, Gordon SC, Heller T, Jhaveri RR, Jonas MM, Kiser JJ, Linas BP, Lo Re V, Peters MG, Reddy KR, Reynolds A, Scott JD, Searson G, Spradling P, Terrault NA, Trooskin SB, Verna EC, Wong JB, Woolley AE, Workowski KA.

Hepatology. 2019 Dec 9. doi: 10.1002/hep.31060. [Epub ahead of print]

PMID:
31816111
7.

Vibration-controlled transient elastography for the detection of cirrhosis in chronic hepatitis D infection.

Da BL, Surana P, Takyar V, Kleiner DE, Heller T, Koh C.

J Viral Hepat. 2019 Nov 19. doi: 10.1111/jvh.13235. [Epub ahead of print]

PMID:
31742822
8.

Healthcare recommendations for Joubert syndrome.

Bachmann-Gagescu R, Dempsey JC, Bulgheroni S, Chen ML, D'Arrigo S, Glass IA, Heller T, Héon E, Hildebrandt F, Joshi N, Knutzen D, Kroes HY, Mack SH, Nuovo S, Parisi MA, Snow J, Summers AC, Symons JM, Zein WM, Boltshauser E, Sayer JA, Gunay-Aygun M, Valente EM, Doherty D.

Am J Med Genet A. 2020 Jan;182(1):229-249. doi: 10.1002/ajmg.a.61399. Epub 2019 Nov 11. Review.

PMID:
31710777
9.

Stimulating More Than Just the Granulocytes: Drug-Induced Liver Injury From Filgrastim.

Sharma D, Da BL, Vittal A, Kapuria D, Heller T, Ben Yakov G.

ACG Case Rep J. 2019 Jun 14;6(6):e00098. doi: 10.14309/crj.0000000000000098. eCollection 2019 Jun.

10.

Reply.

Da BL, Koh C, Heller T.

Hepatology. 2020 Jan;71(1):397-398. doi: 10.1002/hep.30955. Epub 2019 Dec 24. No abstract available.

PMID:
31531987
11.

Chronic hepatitis delta: A state-of-the-art review and new therapies.

Gilman C, Heller T, Koh C.

World J Gastroenterol. 2019 Aug 28;25(32):4580-4597. doi: 10.3748/wjg.v25.i32.4580. Review.

12.

Twitter As a Noninvasive Bio-Marker for Trends in Liver Disease.

Da BL, Surana P, Schueler SA, Jalaly NY, Kamal N, Taneja S, Vittal A, Gilman CL, Heller T, Koh C.

Hepatol Commun. 2019 Jul 13;3(9):1271-1280. doi: 10.1002/hep4.1394. eCollection 2019 Sep.

13.

Exploring the Link Between Platelet Numbers and Vascular Homeostasis Across Early and Late Stages of Fibrosis in Hepatitis C.

Ali RO, Moon MS, Townsend EC, Hill K, Zhang GY, Bradshaw A, Guan H, Hamilton D, Kleiner DE, Auh S, Koh C, Heller T.

Dig Dis Sci. 2019 Aug 12. doi: 10.1007/s10620-019-05760-x. [Epub ahead of print]

PMID:
31407130
14.

Bacterial Translocation and Host Immune Activation in Chronic Hepatitis C Infection.

Moon MS, Quinn G, Townsend EC, Ali RO, Zhang GY, Bradshaw A, Hill K, Guan H, Hamilton D, Kleiner DE, Koh C, Heller T.

Open Forum Infect Dis. 2019 Jul 1;6(7). pii: ofz255. doi: 10.1093/ofid/ofz255.

15.

Portal Pressure in Noncirrhotic Portal Hypertension: To Measure or Not to Measure.

Da BL, Surana P, Kapuria D, Vittal A, Levy E, Kleiner DE, Koh C, Heller T.

Hepatology. 2019 Dec;70(6):2228-2230. doi: 10.1002/hep.30862. Epub 2019 Oct 9. No abstract available.

PMID:
31318454
16.

Vibration Controlled Transient Elastography (Fibroscan®) in sickle cell liver disease - could we strike while the liver is hard?

Ben Yakov G, Sharma D, Alao H, Surana P, Kapuria D, Etzion O, Hsieh MM, Tisdale JF, Fitzhugh CD, Kleiner DE, Levy EB, Chang R, Rivera E, Huang A, Koh C, Heller T.

Br J Haematol. 2019 Oct;187(1):117-123. doi: 10.1111/bjh.16047. Epub 2019 Jun 19.

PMID:
31218662
17.

Evaluation of confocal endoscopic microscopy for detection of early-stage gastric cancer in hereditary diffuse gastric cancer (HDGC) syndrome.

Ruff S, Curtin B, Quezado M, Heller T, Koh C, Steinberg SM, Connolly M, Hernandez JM, Davis JL.

J Gastrointest Oncol. 2019 Jun;10(3):407-411. doi: 10.21037/jgo.2019.01.04.

18.

Severe Hepatotoxicity of Mithramycin Therapy Caused by Altered Expression of Hepatocellular Bile Transporters.

Sissung TM, Huang PA, Hauke RJ, McCrea EM, Peer CJ, Barbier RH, Strope JD, Ley AM, Zhang M, Hong JA, Venzon D, Jackson JP, Brouwer KR, Grohar P, Glod J, Widemann BC, Heller T, Schrump DS, Figg WD.

Mol Pharmacol. 2019 Aug;96(2):158-167. doi: 10.1124/mol.118.114827. Epub 2019 Jun 7.

19.

Lymphocyte-driven regional immunopathology in pneumonitis caused by impaired central immune tolerance.

Ferré EMN, Break TJ, Burbelo PD, Allgäuer M, Kleiner DE, Jin D, Xu Z, Folio LR, Mollura DJ, Swamydas M, Gu W, Hunsberger S, Lee CR, Bondici A, Hoffman KW, Lim JK, Dobbs K, Niemela JE, Fleisher TA, Hsu AP, Snow LN, Darnell DN, Ojaimi S, Cooper MA, Bozzola M, Kleiner GI, Martinez JC, Deterding RR, Kuhns DB, Heller T, Winer KK, Rajan A, Holland SM, Notarangelo LD, Fennelly KP, Olivier KN, Lionakis MS.

Sci Transl Med. 2019 Jun 5;11(495). pii: eaav5597. doi: 10.1126/scitranslmed.aav5597.

20.

Longitudinal effects of Nucleos(t)ide analogue therapy in chronic hepatitis B patients and the utility of non-invasive fibrosis markers during treatment: A single-center experience for up to 17 years.

Surana P, Kapuria D, Broadwell C, Wright EC, Takyar V, Kleiner DE, Ghany MG, Ben-Yakov G, Heller T, Liang TJ, Koh C.

Antiviral Res. 2019 Aug;168:61-67. doi: 10.1016/j.antiviral.2019.05.007. Epub 2019 May 21.

PMID:
31125632

Supplemental Content

Loading ...
Support Center